Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04918_nanopub.RArntHyV6UJY8rTdomYruL0X-s6YFpdfwH7QvUk460FVw#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB04918 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04918 label "Ceftobiprole [drugbank:DB04918]" assertion.
- drugbank:DB04918 seeAlso DB04918 assertion.
- drugbank:DB04918 identifier "drugbank:DB04918" assertion.
- drugbank:DB04918 description "Ceftobiprole is an experimental cephalosporin antibiotic with activity against methicillin-resistant <i>Staphylococcus aureus</i>. It was discovered by Basilea Pharmaceutica and is being developed by Johnson & Johnson Pharmaceutical Research and Development. Ceftobiprole is the first cephalosporin to demonstrate clinical efficacy in patients with infections due to methicillin-resistant staphylococci and, if approved by regulatory authorities, is expected to be a useful addition to the armamentarium of agents for the treatment of complicated skin infections and pneumonia." assertion.
- drugbank:DB04918 title "Ceftobiprole" assertion.
- drugbank:DB04918 bio2rdf_vocabulary:identifier "DB04918" assertion.
- drugbank:DB04918 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04918 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04918" assertion.
- drugbank:DB04918 bio2rdf_vocabulary:x-identifiers.org DB04918 assertion.
- drugbank:DB04918 drugbank_vocabulary:drugbank-id "DB04918" assertion.
- drugbank:DB04918 drugbank_vocabulary:x-cas cas:209467-52-7 assertion.
- drugbank:DB04918 drugbank_vocabulary:x-chemspider chemspider:5293627 assertion.
- drugbank:DB04918 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6918430 assertion.
- drugbank:DB04918 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:12015243 assertion.
- drugbank:DB04918 drugbank_vocabulary:x-wikipedia wikipedia:Ceftobiprole assertion.